1Life Healthcare, Inc.
1Life Healthcare, Inc. (ONEM) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ONEM · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
22
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
1Life Healthcare, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ONEM insider buying and selling by quarter
ONEM insider selling · ONEM insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Recent insider transactions
ONEM executive sell shares · ONEM board member insider trading · ONEM insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 22, 2023 | Thaler Bjorn B CFO | Other | 21,532 | $388K | Form 4 |
| Feb 22, 2023 | Rubin Amir Dan Chair, CEO and President · Director | Other | 99,748 | $1.80M⚡ | Form 4 |
| Feb 22, 2023 | Mango Lisa A General Counsel and Secretary | Other | 88,385 | $1.59M⚡ | Form 4 |
| Feb 22, 2023 | Diamond Andrew S Chief Medical Officer | Other | 23,620 | $425K | Form 4 |
| Feb 22, 2023 | Agarwal Vikas CAO | Other | 8,866 | $160K | Form 4 |
| Feb 22, 2023 | TOCIO MARY ANN Director | Other | 47,298 | $851K | Form 4 |
| Feb 22, 2023 | TAYLOR SCOTT C Director | Other | 7,753 | $140K | Form 4 |
| Feb 22, 2023 | Lewis-Hall Freda C Director | Other | 4,534 | $82K | Form 4 |
| Feb 22, 2023 | Kennedy David P Director | Other | 250,779 | $4.51M⚡ | Form 4 |
| Feb 22, 2023 | Kalen Holmes Director | Other | 4,534 | $82K | Form 4 |
| Feb 22, 2023 | DUNLEVIE BRUCE Director | Other | 665,257 | $11.97M⚡ | Form 4 |
| Feb 22, 2023 | Blumenkranz Mark S. Director | Other | 4,534 | $82K | Form 4 |
| Feb 22, 2023 | Auvil Paul R. III Director | Other | 12,586 | $227K | Form 4 |
| Feb 15, 2023 | Thaler Bjorn B CFO | Option | 13,829 | — | Form 4 |
| Feb 16, 2023 | Thaler Bjorn B CFO | Sale | 6,015 | $92K | Form 4 |
| Feb 15, 2023 | Mango Lisa A General Counsel and Secretary | Option | 2,221 | — | Form 4 |
| Feb 15, 2023 | Mango Lisa A General Counsel and Secretary | Option | 11,525 | — | Form 4 |
| Feb 16, 2023 | Mango Lisa A General Counsel and Secretary | Sale | 7,596 | $117K | Form 4 |
| Feb 17, 2023 | Mango Lisa A General Counsel and Secretary | Sale | 6,150 | $94K | Form 4 |
| Feb 15, 2023 | Diamond Andrew S Chief Medical Officer | Option | 1,776 | — | Form 4 |
| Feb 15, 2023 | Diamond Andrew S Chief Medical Officer | Option | 11,525 | — | Form 4 |
| Feb 15, 2023 | Agarwal Vikas CAO | Option | 829 | — | Form 4 |
| Feb 15, 2023 | Agarwal Vikas CAO | Option | 4,303 | — | Form 4 |
| Feb 16, 2023 | Agarwal Vikas CAO | Sale | 2,117 | $33K | Form 4 |
| Jan 15, 2023 | DUNLEVIE BRUCE Director | Award | 1,051 | — | Form 4 |
Rubin Amir Dan
Chair, CEO and President · Director
Date
Feb 22
Shares
99,748
Price
$18.00
Value
$1.80M ⚡
Mango Lisa A
General Counsel and Secretary
Date
Feb 22
Shares
88,385
Price
$18.00
Value
$1.59M ⚡
Diamond Andrew S
Chief Medical Officer
Date
Feb 22
Shares
23,620
Price
$18.00
Value
$425K
Mango Lisa A
General Counsel and Secretary
Date
Feb 15
Shares
2,221
Price
—
Value
—
Mango Lisa A
General Counsel and Secretary
Date
Feb 15
Shares
11,525
Price
—
Value
—
Mango Lisa A
General Counsel and Secretary
Date
Feb 16
Shares
7,596
Price
$15.36
Value
$117K
Mango Lisa A
General Counsel and Secretary
Date
Feb 17
Shares
6,150
Price
$15.32
Value
$94K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ONEM insider trading
ONEM insider trades
1Life Healthcare, Inc. (ONEM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ONEM. Over the past 12 months, 0 insiders have filed transactions with the SEC. ONEM insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For 1Life Healthcare, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ONEM insider trading · 5 questionsThe insiders of 1Life Healthcare, Inc. (ONEM) include executives and directors such as ONEM, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026